Loading viewer...
investor_presentation
Format: PDF investor_presentation
This document presents Argenx's half-year financial results and business updates, highlighting innovations in immunology and future pipeline opportunities.
earnings_deck
investor_presentation
25 Pages
Kapsch TrafficCom
Regeneron Pharmaceuticals Investor Presentation — September 2022
investor_presentationinvestor_presentation
42 Pages
Regeneron Pharmaceuticals, Inc.